Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-28T01:41:54.732Z Has data issue: false hasContentIssue false
  • English
  • Français

Anticoagulation in Cerebral Embolism

Published online by Cambridge University Press:  18 September 2015

Edward Bass
Edward Bass*
Affiliation:
Department of Neurosciences, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec
*
Department of Internal Medicine, Division of Neurology, Box 19, University of South Florida, 12901 North 30th Street, Tampa, Florida 33612.
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A case of presumed anticoagulant induced hemorrhage into infarction is presented along with a retrospective study of 110 cases of cerebral embolus.

An accurate recommendation for the timing of anticoagulation following cerebral embolism hinges on balancing the risk of hemorrhage into infarction against the benefits of early treatment attributed to preventing recurrent embolism. It is felt that the present literature, concepts of pathogenesis and experimental data provide insufficient information to make absolute clinical decisions. The available evidence implies that the risk of further embolic events is three to four times that of hemorrhage into infarction, yet additional randomized prospective studies and better experimental models are needed to establish a valid treatment plan. It may be possible to distinguish separate mechanisms underlying early diffuse hemorrhage into infarction from sudden delayed massive hematoma formation.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 10 , Issue 1 , February 1983 , pp. 32 - 36
Copyright
Copyright © Canadian Neurological Sciences Federation 1983

References

Adams, G.F., Merrett, J.D., Hutchison, W.M., and Pollock, A.M. (1974). Cerebral embolism and mitral stenosis: survival with and without anticoagulants. J. Neurol. Neurosurg. Psych., 37, 378–383.CrossRefGoogle ScholarPubMed
Adams, R.D., and Vander Eecken, H.M. (1952). Vascular diseases of the brain. Ann. Rev. Med., 4, 213–252.CrossRefGoogle Scholar
Baker, R.N., Broward, J.A., Fang, H.C., Fisher, C.M., Groch, S.N., Heyman, A., Karp, H.R., McDevitt, E., Scheinberg, P., Schwartz, W., and Toole, J.F. (1962). Anticoagulant therapy in cerebral infarction. Neurology, 12, 823–835.CrossRefGoogle ScholarPubMed
Bharucha, N.E., Wolf, P.A., Kanrel, W.B., and McNamara, P.M. (1981). Epidemiological study of cerebral embolism. The framingham study. Neurol., 10, 105.Google Scholar
Brain, R. (1957). Order and disorder in the cerebral circulation. Lancet, 2, 857–862.CrossRefGoogle Scholar
Brown, T.R., and Poskanzer, D.C. (1969). Treatment of strokes. NEJM, 281, 594–602, 650–657.CrossRefGoogle Scholar
Carter, A.B. (1964). Anticoagulants in rheumatic heart disease. BMJ, 2, 55.CrossRefGoogle Scholar
Carter, A.B. (1965). Prognosis of cerebral embolism. Lancet, 2, 514–519.CrossRefGoogle ScholarPubMed
Cosgriff, S. (1950). Prophylaxis of recurrent embolism of intracardiac origin. JAMA, 143, 870–872.CrossRefGoogle ScholarPubMed
Cosgriff, S.W. (1953). Chronic anticoagulant therapy in recurrent embolism of cardiac origin. Ann Int Med, 38, 278–287.Google ScholarPubMed
Daley, R., Mattingly, T.W., Holt, C.L., Bland, E.F., and White, P.D. (1951). Systemic arterial embolism in rheumatic heart disease. Amer Heart J, 42, 566–581.CrossRefGoogle ScholarPubMed
Darling, R.C., Austen, W.G., and Linton, R.R. (1967). Arterial embolism. Surg Gynec Obst, 124, 106–114.Google ScholarPubMed
Duff, I.F. (1950). The effectiveness of anticoagulant therapy as observed in 303 cases. Angiologica, 1, 170–193.CrossRefGoogle ScholarPubMed
Easton, J.D., and Sherman, D.G. (1980). Management of cerebral embolism of cardiac origin. Stroke, 11, 433–442.CrossRefGoogle ScholarPubMed
Fisher, M., and Adams, R.D. (1951). Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J. Neuropath Exp Neurol, 10, 92–93.Google Scholar
Fleming, H.A., and Bailey, S.M. (1971). Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J, 47, 599–604.CrossRefGoogle ScholarPubMed
Foley, W.T. (1955). In transactions of a conference held under the auspices of the American Heart Association. Ed. Wright, I.S., and Luckey, E.H.Grune and Stratton. 153.Google Scholar
Frazier, S.H., Hill, N.C., Wakim, K.G., Sayre, G.P., Millikan, C.H., and Whisnant, J.P. (1957). Influence of anticoagulants on cerebral infarction produced by homologous blood clots. Proc Mayo Clin, 32, 717–722.Google ScholarPubMed
Furlan, A.J., Cavalier, S.J., Hobbs, R.E., and Weinstein, M.A. (1981). Risk of hemorrhage and timing of anticoagulation after non-septic embolic infarction. Neurology, 31(2), 55–56.Google Scholar
Genton, E., Barnett, H.J.M., Fields, W.S., Gent, M., and Hoak, J.C. (1977). XIV cerebral ischemia: The role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy. Stroke, 8, 150–175.CrossRefGoogle Scholar
Hill, N.C., Millikan, C.H., Wakim, K.G., and Sayre, G.P. (1955). Studies in cerebrovascular disease. Experimental production of cerebral infarction by intracarotid injection of homologous blood clot, preliminary report. Proc Mayo Clin, 30, 625–633.Google ScholarPubMed
Howell, D.A., Tatlow, W.F.T., and Feldman, S. (1964). Observations on anticoagulant therapy in thromboembolic disease of the brain. CMAJ, 90, 611–614.Google ScholarPubMed
Iizuka, J. (1972). Intracranial and infraspinal hematomas associated with anticoagulant therapy. Neurochirgia, 1, 15–25.Google Scholar
Marshall, J. (1976). The management of cerebrovascular disease. 3rd ed. Blackwell Scientific Publications, 112.Google Scholar
McDevitt, E., Carter, S.A., Gatje, B.W., Foley, W.T., and Wright, I.S. (1958). Use of anticoagulants in treatment of cerebral vascular disease. JAMA, 166, 592–597.CrossRefGoogle ScholarPubMed
McDevitt, E. (1961). Anticoagulant therapy in cerebral vascular disease. Third conference. Ed. Millikan, C.H., Siekert, R.G., and Whisnant, J.P., Grune and Stratton, New York, 90–93.Google Scholar
Meyer, J.S. (1958). Localized changes in properties of the blood and effects of anticoagulant drugs in experimental cerebral infarction. NEJM, 258, 151–159.CrossRefGoogle ScholarPubMed
Millikan, C.H. (1979). Anticoagulant therapy to prevent cerebral infarction. Med Clin N Amer, 63, 897–904.CrossRefGoogle ScholarPubMed
Moyes, P.D., Wakin, K.G., Sayre, G.P., and Millikan, C.H. (1955). Studies in cerebrovascular disease VI. Experimental cerebral infarction. A study of different techniques. Proc Mayo Clin, 30, 620–625.Google Scholar
Olsson, Y., Crowell, R.M., and Klatzo, I. (1971). The blood-brain barrier to protein tracers in focal cerebral ischemia and infarction caused by occlusion of the middle cerebral artery. Acta Neuropath, 18, 89–102.CrossRefGoogle ScholarPubMed
Peterman, A.F., Wakim, K.G., Sayre, G.P., Whisnant, J.P., and Millikan, C.H. (1960). Effects of delayed anticoagulant therapy on experimental cerebral infarcts. J. Neuropath Exp Neurol, 18, 263–269.CrossRefGoogle Scholar
Reichel, F. (1968). Anticoagulants and cerebral embolism. JAMA, 203, 59.CrossRefGoogle ScholarPubMed
Sage, J.I., Van Uitert, R.L. and Duvoisin, R.C. (1981). Differences in mortality, morbidity and recurrence of cerebral ischemia in patients with atrial fibrillation on the basis of arteriosclerotic and rheumatic heart disease. Annals Neurology, 10, 104.Google Scholar
Sibley, W.A., Morledge, J.H., and Lapham, L.W. (1957). Experimental cerebral infarction. The effects of Dicumarol. Amer J. Med Sci, 234, 663–677.CrossRefGoogle ScholarPubMed
Stephans, C.A.L. (1954). Anticoagulant therapy in private practice. Circulation, 9, 682–686.CrossRefGoogle Scholar
Symonds, C. (1956). Cerebrovascular Accidents. Practitioner, 176, 130–136.Google ScholarPubMed
Szekely, P. (1964). Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. BMJ, 1, 1209–1212.CrossRefGoogle ScholarPubMed
Vastola, E.F., and Frugh, A. (1959). Anticoagulants for occlusive cerebrovascular lesions. Neurology, 9, 143–148.CrossRefGoogle ScholarPubMed
Wells, C.E. (1959). Cerebral embolism. The natural history, prognostic signs and effects of anticoagulation. AMA Archiv Neurol Psychiat, 81, 667–677.CrossRefGoogle ScholarPubMed
Whisnant, J.P., Millikan, C.H., Sayre, G.P. and Wakim, K.G. (1959). Effect of anticoagulants on experimental cerebral infarction. Clinical implications. Circulation, 20, 56–65.CrossRefGoogle ScholarPubMed
Wright, L.T., and Rothman, M. (1951). Deaths from Dicumarol. Arch Surg. 62, 23–28.CrossRefGoogle ScholarPubMed
Case records of the Massachusetts General Hospital (1962). Ed. Castleman, B., and Kibee, B.U.NEJM, 267, 1085–1091.CrossRefGoogle Scholar